TDG

TransDigm Acquires Raptor Labs for $655M

Transdigm Group Incorporated (NYSE: TDG) has successfully completed its acquisition of Raptor Labs Holdco, LLC ("Raptor Scientific") for approximately $655 million in cash, including certain tax benefits. The acquisition was financed through cash on hand. Raptor Scientific is a leading global manufacturer of complex test and measurement solutions primarily serving the aerospace and defense end markets. The company is expected to generate approximately $90 million in revenue for the calendar year ending December 31, 2024. Additionally, Raptor Scientific employs approximately 170 people and has manufacturing locations in Livermore, CA; Woodland Hills, CA; Berlin, CT; Huntsville, AL; and Peterborough, NH.

Transdigm Group, through its wholly-owned subsidiaries, is a leading global designer, producer, and supplier of highly engineered aircraft components for use on nearly all commercial and military aircraft in service today. Major product offerings include mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized ac/dc electric motors and generators, and more.

The acquisition of Raptor Scientific is expected to bolster Transdigm Group's position in the aerospace and defense industry with the addition of Raptor Scientific's highly engineered, proprietary components with significant aftermarket content and a strong presence across major aerospace and defense platforms.

No specific financial metrics for Transdigm Group's performance since the last reporting period are provided in the press release. The market has reacted to these announcements by moving the company's shares 2.6% to a price of $1296.89. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS